Biotech

All Articles

ArsenalBio elevates $325M, turns far from previous lead possession

.Collection Biosciences is carrying on up. The cell treatment business has added on $325 thousand in...

Lilly- backed weight-loss biotech data IPO

.After raising $170 thousand back in February, metabolic disease-focused BioAge Labs has actually fi...

Aelis' marijuana make use of medicine fails phase 2b, steering Indivior to reconsider $100M option

.Aelis Farma's chances of safeguarding an easy, favorable selection on a $one hundred million possib...

ProKidney halts stage 3 trial certainly not needed for tissue treatment approval

.ProKidney has actually stopped among a set of phase 3 trials for its tissue treatment for kidney he...

Vaxcyte climbs on 'spectacular' 31-valent PCV succeed against Pfizer

.Vaxcyte unveiled what experts named "sensational" period 1/2 records for its 31-valent pneumococcal...

Recursion's human brain ailment trial reveals scant proof of efficacy

.Recursion has actually stumbled by means of a very early exam of its own tech-enabled strategy to d...

Acepodia, Pfizer click on with each other for chemistry-based cell treatment

.Phone it a situation of good chemical make up: Acepodia, a biotech based on Nobel Prize-winning sci...

Praxis epilepsy medicine reduces confiscations in stage 2 litigation

.Praxis Preciseness Medicines has scored another midphase win in epilepsy this year, along with its ...

Three officers resign as Dyne messages mixed information for DMD applicant

.After leaving a clinical grip numerous years back, Dyne Therapeutics has actually exposed brand-new...

Arrowhead fires off phase 3 information in unusual metabolic illness in front of market clash with Ionis

.Arrowhead Pharmaceuticals has shown its own hand before a potential showdown with Ionis, posting ph...